Revelation Biosciences, Inc.
REVB
$1.24
-$0.02-1.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.91M | -8.13M | -8.46M | -14.41M | -15.04M |
| Total Depreciation and Amortization | 27.10K | 28.40K | 28.80K | 28.80K | 27.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 623.00K | 304.30K | 325.70K | 377.60K | 112.50K |
| Change in Net Operating Assets | -5.90K | -2.25M | -9.61M | -4.28M | -3.42M |
| Cash from Operations | -8.27M | -10.05M | -17.72M | -18.28M | -18.32M |
| Capital Expenditure | -- | 17.70K | 0.00 | 0.00 | -19.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 17.70K | 0.00 | 0.00 | -19.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.51M | 16.20M | 10.82M | 7.43M | 12.85M |
| Repurchase of Common Stock | -41.20K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.47M | 16.20M | 10.82M | 7.43M | 12.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.20M | 6.17M | -6.90M | -10.85M | -5.49M |